ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Time-Out For A New Sense Of Cooperation, Urgency.

January 21, 2000

AACI To Become More Aggressive In Developing National Issues; Planning To Start on Collaborate Diagnosis Network

July 15, 1983

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December 12, 2003

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002